Name: BBOT Balance Sheet - Bridgebio Oncology Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BBOT - Bridgebio Oncology Therapeutics, Inc.

USD | NASDAQ | Healthcare

BBOT Balance Sheet - Bridgebio Oncology Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	373.7	30.9	-	-
Restricted Cash	-	-	-	-
Short Term Investments	51.8	124.8	-	-
Cash And Short Term Investments	425.5	155.6	-	-
Receivables
Accounts Receivable	-	-	-	-
Current Assets
Inventory	-	-	-	-
Prepaid Expenses	6.6	3.0	-	-
Other Current Assets	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-
Accumulated Depreciation	-	-	-	-
Property,Plant & Equipment Net	1.0	0.5	-
Current Liabilities
Accounts Payable	1.4	3.1	-	-
Short Term Debt	-	-	-	-
Deferred Revenue Current	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-
Operating Lease Liabilities Non-Current	2.2	0.0	-	-
Deferred Revenue Non-Current	-	-	-
Common Equity
Common Stock	0.0	0.0	-	-
Additional Paid In Capital	767.6	43.5	0.0	-
Retained Earnings	(356.6)	(222.5)	(0.1)
Supplementary Data
Total Debt	-	-	-	-
Net debt	-	-	-	-
Working Capital	397.4	139.1	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	52.7	373.7	408.7	-	-	30.9	-	-	1.8	-	-	-	-	-
Restricted Cash	-	-	408.9	-	-	31.0	-	-	-	-	-	-	-	-
Short Term Investments	199.6	51.8	59.5	-	-	124.8	-	-	-	-	-	-	-	-
Cash And Short Term Investments	252.3	425.5	468.3	-	-	155.6	-	-	1.8	-	-	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Liabilities
Accounts Payable	12.1	1.4	3.7	-	-	3.1	-	-	-	-	-	-	-	-
Short Term Debt
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current
Common Equity
Common Stock	0.0	0.0	0.0	-	-	0.0	-	-	0.0	-	-	-	-	-
Additional Paid In Capital
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)